NEW YORK and CAESAREA, Israel, March 14, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that the previously announced earnings release and conference call to report its fourth quarter year end 2017 results has been revised. The Company will now release its earnings results on Monday, March 19, 2018 prior to market open with a conference call to follow at 9:00am EDT.
The Company will discuss its fourth quarter and year end 2017 operating and financial results and its strategy and outlook for 2018. The conference call will be hosted by Erez Raphael, Chief Executive Officer, and Zvi Ben-David, Chief Financial Officer. The live conference call can be accessed by dialing 1-877-407-8035 or 1-201-689-8035 (international). Participants should ask for the DarioHealth Earnings Conference Call. The conference call will also be available via live webcast at: http://www.investorcalendar.com/event/26834
Revised Conference Call Details:
Date: Monday, March 19, 2018
Time: 9:00am EDT
Dial-in Number: 1-877-407-8035
International Dial-in Number: 1-201-689-8035
Participants are recommended to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through April 2, 2018. To listen to the replay, dial 1-877-481-4010 (domestic) or 1-919-882-2331 (international) and use replay passcode 26834. The webcast replay will be available through June 19, 2017.
About DarioHealth Corp.
DarioHealth Corp. (NASDAQ: DRIO) is a leading global digital health company serving its users with dynamic mobile health solutions. In today's day and age, knowledge of health and treatment is being democratized, and we believe people deserve to know everything about their own health and have the best tools to manage their condition. DarioHealth employs a revolutionary approach whereby harnessing big data, we have developed a novel method for chronic disease data management, empowering people to analyze and personalize self-diabetes management in a totally new way without having the disease slow them down. DarioHealth has a commercial office in New York with an R&D center in Caesarea, Israel. For more information, visit http://mydario.investorroom.com/.
DarioHealth Corporate Contact: Shmuel Herschberg, Marketing Director, email@example.com, +1-914-775-5548
DarioHealth Public Relations Contact: Terese Kelly, Rosica PR, firstname.lastname@example.org, +1-201-843-5600
DarioHealth Investor Relations Contact: Westwicke Partners, Dario@Westwicke.com, +1-443-213-0500
SOURCE DarioHealth Corp.